Biodexa Pharmaceuticals plc (BDRX) Total Assets by Year
Biodexa Pharmaceuticals plc closed fiscal year 2025 with $24.4M in total assets, $9.1M in total liabilities and $15.3M in shareholder equity. Total assets rose 32.1% from the prior fiscal year. The table below carries 11 fiscal years, from 2015 to 2025, and the quarters Biodexa Pharmaceuticals plc has filed alongside them.
Annual figures, oldest first. Point at a bar to read its period.
BDRX Balance Sheet by Fiscal Year
Figures are as reported in USD. Each change compares the year with the year before it, and each column links to the filing it was taken from.
| Metric | FY2520-F | FY2420-F | FY2320-F | FY2220-F | FY2120-F | FY2020-F | FY1920-F | FY1820-F | FY1720-F | FY1620-F | FY1520-F |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Assets | $24.4M+32.1% | $18.5M+37.8% | $13.4M+101.3% | $6.7M-61.7% | $17.4M+30.0% | $13.4M-67.3% | $41.0M+57.1% | $26.1M-60.8% | $66.6M-4.8% | $69.9M-25.9% | $94.4M |
| Total Liabilities | $9.1M+12.7% | $8.1M+8.2% | $7.5M+161.8% | $2.9M-14.1% | $3.3M-21.5% | $4.2M-71.9% | $15.0M+234.8% | $4.5M-77.2% | $19.7M+45.5% | $13.5M-46.5% | $25.3M |
| Total Equity | $15.3M+47.2% | $10.4M+74.8% | $6.0M+56.1% | $3.8M-72.9% | $14.1M+53.7% | $9.2M-64.6% | $26.0M+20.1% | $21.6M-54.0% | $46.9M-16.8% | $56.4M-18.4% | $69.1M |
BDRX Balance Sheet by Quarter
Figures are as reported in USD. Each change compares the quarter with the same quarter a year earlier.
| Metric | Q4'2520-F | Q2'256-K | Q4'2420-F | Q2'246-K | Q4'2320-F | Q2'236-K | Q4'2220-F | Q2'226-K | Q4'2120-F | Q4'2020-F | Q4'1920-F | Q4'1820-F |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Assets | $24.4M+32.1% | $20.3M+15.2% | $18.5M+37.8% | $17.7M+74.5% | $13.4M+101.3% | $10.1M+4.5% | $6.7M-61.7% | $9.7M | $17.4M+30.0% | $13.4M-67.3% | $41.0M+57.1% | $26.1M-60.8% |
| Total Liabilities | $9.1M+12.7% | $4.6M-29.8% | $8.1M+8.2% | $6.6M+95.7% | $7.5M+161.8% | $3.4M+54.5% | $2.9M-14.1% | $2.2M | $3.3M-21.5% | $4.2M-71.9% | $15.0M+234.8% | $4.5M-77.2% |
| Total Equity | $15.3M+47.2% | $15.7M+42.3% | $10.4M+74.8% | $11.0M+63.8% | $6.0M+56.1% | $6.7M-10.1% | $3.8M-72.9% | $7.5M | $14.1M+53.7% | $9.2M-64.6% | $26.0M+20.1% | $21.6M-54.0% |
What total assets means
Total assets is everything the company owns on the balance sheet date, total liabilities is everything it owes, and the difference between them is the equity that belongs to shareholders.
More Biodexa Pharmaceuticals plc financials
Frequently Asked Questions
What was Biodexa Pharmaceuticals plc's total assets in fiscal year 2025?
Biodexa Pharmaceuticals plc closed fiscal year 2025 with $24.4M in total assets, $9.1M in total liabilities and $15.3M in shareholder equity.
How fast is Biodexa Pharmaceuticals plc's total assets growing?
Biodexa Pharmaceuticals plc (BDRX) total assets rose by 32.1% year over year, from $18.5M to $24.4M in fiscal year 2025.
How has Biodexa Pharmaceuticals plc's total assets changed over the years?
Across the 11 fiscal years this page covers, Biodexa Pharmaceuticals plc (BDRX) total assets went from $94.4M in fiscal year 2015 to $24.4M in fiscal year 2025.
What was Biodexa Pharmaceuticals plc's total assets in the most recent quarter?
Biodexa Pharmaceuticals plc (BDRX) reported $24.4M in total assets in Q4 2025. This represents an increase of 32.1% from the same quarter a year earlier.
What does total assets mean on a financial statement?
Total assets is everything the company owns on the balance sheet date, total liabilities is everything it owes, and the difference between them is the equity that belongs to shareholders. This page lists what Biodexa Pharmaceuticals plc (BDRX) reported on that line in every period on record.